We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Can't Deduct $50M Legal Fees For FDA Approval, IRS Says

By David Hansen · December 3, 2018, 8:10 PM EST

The $50 million Mylan Inc. spent on patent litigation after applying for a license to sell a generic copy of a drug is not a tax-deductible business expense because it was...

To view the full article, register now.